29 reports

Gastric Cancer Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global gastric cancer drugs market as it emerges from the COVID 19 shut down. Description: Where is...

  • Gastric Cancer
  • World
  • Health Expenditure
  • Gross Domestic Product Per Capita

Major players in the gastric cancer drugs market are Eli Lilly and company, Novartis, Merck KGaA, Otsuka Pharmaceutical, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Bristol-Myers Squibb, Sanofi, Pfizer Inc., AstraZeneca, Bayer Healthcare, Abbott, AROG Pharmaceuticals, Ipsen Biopharmaceuticals, Array Biopharma, Taiho Oncology, AstraZeneca, ARIAD...

  • Gastric Cancer
  • World
  • Europe
  • United States
  • Japan
  • Middle East
  • APAC
  • Drug Approval

Gastric Cancer (Oncology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Drugs In Development, 2021, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.Gastric cancer, also called stomach cancer, is a malignant...

  • Gastric Cancer
  • World

Major players in the gastric cancer drugs market are Eli Lilly and company, Novartis, Merck KGaA, Otsuka Pharmaceutical, and F. Hoffmann-La Roche. The global gastric cancer drugs market is expected to decline from $2.9 billion in 2020 to $2.88 billion in 2021 at a compound annual growth rate (CAGR) of -0.7%. The slow decline is mainly...

  • Gastric Cancer
  • World
  • Europe
  • Japan
  • United States
  • APAC
  • Drug Approval

Gastric Cancer - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Pipeline Review, H2 2020, provides an overview of the Gastric Cancer (Oncology) pipeline landscape. Gastric cancer, also called stomach cancer, is a malignant...

  • Gastric Cancer
  • World

Gastric Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Pipeline Review, H1 2020, provides an overview of the Gastric Cancer (Oncology) pipeline landscape. Gastric cancer, also called stomach cancer, is a malignant...

  • Gastric Cancer
  • World

Catheter Market Research Report: By Type (Cardiovascular, Urological, Gastrointestinal, Neurovascular, Ophthalmic), Shape (Pigtail, Judkins Left, Judkins Right, Bypass, Amplatz), End User (Hospitals and Ambulatory Surgical Centers, Homecare Settings, Diagnostic Centers) - Global Industry Analysis and Growth Forecast to 2030 The...

  • Cardiovascular Disease
  • Catheter
  • Medical Device
  • Gastric Cancer
  • World
  • Chronic Disease Prevalence

Gastric Cancer Therapy Market Report Overview Gastric Cancer Therapy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Gastric Cancer Therapy market types and applications. It is a focused study on Gastric Cancer Therapy market space...

  • Gastric Cancer
  • World
  • Health Provider Density

Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market 2022-2026 The analyst has been monitoring the HER2 (human epidermal growth factor receptor 2) inhibitors market and it is poised to grow by $ 8.00 bn during 2022-2026 progressing at a CAGR of 8.95% during the forecast period. Our report on the HER2...

  • Breast Cancer
  • Marketing Research
  • Gastric Cancer
  • World

Gastric Cancer Therapy market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Gastric Cancer Therapy Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Gastric Cancer Therapy types, applications. Further, Gastric...

  • Gastric Cancer
  • World

Endoscopic Submucosal Dissection Market - Scope of the Report The analyst recently published a market study on the global endoscopic submucosal dissection market.The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about...

  • Health Services
  • Gastric Cancer
  • World

Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market: About this market This HER2 inhibitors market analysis considers sales from both monotherapy and combination therapy. Our analysis also considers the sales of HER2 inhibitors in Asia, Europe, North America, and ROW. In 2018, the monotherapy segment...

  • Breast Cancer
  • Gastric Cancer
  • World

Summary Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer.It offers lead products such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxcolorectal, a prognostic...

  • Healthcare
  • Bladder Cancer
  • Gastric Cancer
  • New Zealand
  • Medical Devices Sales

This study covers the world outlook for gastric cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the...

  • Monoclonal Antibody
  • Gastric Cancer
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for gastric cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

  • Gastric Cancer
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for gastric cancer diagnostics, screenings, and treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region,...

  • Gastric Cancer
  • World
  • Gross Domestic Product
  • Disposable Income

Summary Bioprognos SL (Bioprognos) is a cancer diagnostics company that develops non-invasive and accurate diagnostics solutions.The company’s pipeline products include OncoBREAST Dx, OncoLUNG Dx, OncoOVARIAN Dx, OncoPROSTATE Dx, OncoCUP Dx, OncoLIVER Dx, OncoNECK Dx, OncoBLADDER Dx, and OncoCOLON Dx. It offers IOTA’s...

  • Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Gastric Cancer
  • Cancer Diagnostics
  • Clinical Trial
  • Europe
  • Medical Devices Sales

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 Summary Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, stomach pain, vomiting, weight loss that is unintentional, feeling...

  • Gastric Cancer
  • Esophageal Cancer
  • Prescription Drug Sales
  • Biologics Penetration Rate

Drug Overview Napabucasin (Dainippon Sumitomo) is designed to selectively and simultaneously inhibit multiple key pathways associated with tumor growth and development by targeting the STAT3 transcription factor. STAT3 activation contributes to growth stimulation, angiogenesis, and resistance to apoptosis, which are all...

  • Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer

Global Gastrointestinal Stents Market: Scope of Study This report on gastrointestinal stents market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of gastrointestinal...

  • Cancer
  • Esophageal Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • World

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies Summary Gastric cancer is characterized by the formation of malignant cells in the inner lining of the stomach, and is the fifth most common cancer globally. Due to its indolent nature it...

  • Gastric Cancer
  • Therapy
  • World
  • APAC
  • Mortality Rate
  • Cancer Mortality

Gastric cancer

4385 5000 3900

Pipeline therapies will look to fulfil many areas of high unmet need left by the lack of targeted therapies approved for the treatment of gastric cancer. This report addresses the following questions: - What impact will the PD-1/PD-L1 inhibitor class of drugs have on the gastric cancer market? - How will pipeline immunotherapies...

  • Gastric Cancer
  • Japan
  • United States
  • European Union
  • Smoking Prevalence
  • Cancer Incidence

Disease Overview Gastric cancer is the second-leading cause of cancer-related mortality worldwide. There is significant geographic variation in the burden of the disease: incidence and mortality are notably high in East Asia, China, Eastern Europe, and Latin America, whereas the disease is no longer as common in North...

  • Gastric Cancer
  • World
  • East Asia
  • Western Europe
  • China
  • North America
  • Eastern Europe
  • Latin America
  • Smoking Prevalence

Summary Miraculins Inc. (Miraculins) is a biotechnology company that offers therapeutic products. The company acquires, develops and commercializes risk assessment tests, and non invasive diagnostic tests for the healthcare market. It provides discovery and validation of cancer biomarkers for development of diagnostic tools and...

  • Diagnostics
  • Clinical Trial
  • Gastric Cancer
  • Pancreatic Cancer
  • Colorectal Cancer
  • Canada
  • United States
  • China
  • Prescriptions Filled
  • In Store Traffic

Frontier Pharma: Gastric Cancer - Early Stage Pipeline Innovation Shows Shift Towards Targeted mAbs Summary Gastric cancer is the fifth most common cancer globally, and due to its indolent nature remains one of the most common causes of cancer-related death worldwide. Such a poor outlook, particularly for patients...

  • Gastric Cancer
  • United States
  • World
  • Europe
  • Japan
  • Drug Approval
  • Medical Technology Density

Cancer is a condition where an error or mutation in the cell’s DNA occurs, causing it to grow at a rapid rate. A cancer cell continues living while a normal cell would die, thus, accumulating to form a tumor that can break off and spread throughout the body. Gastric cancer is when such a condition occurs in the stomach and has the tendency...

  • Gastric Cancer
  • World
  • United States
  • Smoking Prevalence
  • Spending On Medicines

Summary Oryzon Genomics S.A. (Oryzon) is a clinical stage biopharmaceutical company that offers development of epigenetics-based therapeutics. The company offers epigenetics, a regulatory system that controls gene expression without affecting the makeup of the genes themselves and provides regulation of gene transcription that...

  • Genomics
  • Gastric Cancer
  • Prostate Cancer
  • Diagnostics
  • Stomach Cancer
  • Spain

Market outlook of the global gastric cancer drugs market Technavio’s market research analyst predicts the global gastric cancer drugs market to grow rapidly at a CAGR of approximately 8% during the forecast period. The presence of huge unmet needs in the market is expected to result in this market’s healthy growth during the forecast period....

  • Gastric Cancer
  • Pharmaceutical
  • Japan
  • North America
  • Drug Approval
  • Health Expenditure

This BCC Research report reviews global markets for biologic therapeutics for gastric cancer and forecasts trends for use of diagnostics, screening and cancer treatment through 2020. Highlights -The global gastric cancer diagnostic/screening and treatment market totaled $235.5 billion in 2014. This market is expected...

  • Therapy
  • Gastric Cancer
  • World
  • Lead Sales